Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
Reuters: Generic drug sector seeks policy fixes after Trump tariff threat
“Imposing massive tariffs on generic medicines risk making lower-cost generic drugs millions of Americans rely on more expensive and harder to access,” said Merith Basey, CEO of Patients For Affordable Drugs, a patient advocacy organization.
News and Reports
Healthcare Finance: FTC announces settlement with Caremark, resolving PBM lawsuit
Caremark, Express Scripts and OptumRx control roughly 80% of prescriptions filled in the United States, according to Patients for Affordable Drugs. Merith Basey, CEO of Patients for Affordable Drugs, said, “We welcome today’s settlement curbing the power of PBM giants Caremark, Express Scripts and OptumRx who control the vast majority of America’s prescriptions.”
News and Reports
“To build a fairer, more transparent drug market, lawmakers must continue pursuing reforms that hold both drug makers and pharmacy benefit managers accountable for abusive practices that drive up costs for patients — while also working to prevent them in the first place,” said Merith Basey, who heads Patients For Affordable Drugs, an advocacy group, […]
News and Reports
STATEMENT: P4AD Responds to Third FTC Settlement Addressing Big Three PBM Price-Gouging
WASHINGTON, D.C. — With today’s Caremark settlement, the Federal Trade Commission (FTC) has now reached settlements with all three of the nation’s largest Pharmacy Benefit Managers (PBMs), resolving claims that CVS Caremark, Cigna’s Express Scripts, and OptumRx engaged in practices that artificially inflated insulin prices and harmed patients. In response, Merith Basey, CEO of Patients For Affordable […]
News and Reports
Deseret News: When medical needs and financial realities collide
The national organization Patients for Affordable Drugs collects stories from people who struggle with prescription costs in particular. They have a map of the states that link to patient stories. Said the group’s CEO, Merith Basey, “The prescription drug pricing system in the U.S. is rigged against patients, which is why 1 in 3 people […]
News and Reports
Pink Sheet: US Pushing Foreign Countries To Pay More For Drugs: Will It Help Americans?
Patients for Affordable Drugs (P4AD), a patient advocacy group, acknowledged a well-designed MFN policy could deliver lower prices for patients and taxpayers. But the group said the 17 existing MFN deals depend on voluntary industry participation and fall short of the systemic reforms. “The terms of the deals remain secret, leaving unanswered questions about the […]
News and Reports
Inside Health Policy: Survey Shows Voters Favor Commitment To MFN Pricing Policies
Patients for Affordable Drugs CEO Merith Basey says the MFN agreements the government has established so far lack the longevity, transparency and oversight to combat a broken system in need of urgent structural change, but it is possible for the policy to be improved. “Since U.S. brand name drugs are priced at least 4 times […]
News and Reports
The Hill: Big Pharma lost in court — Congress must not bail it out
For the last three years, some of the most profitable corporations in the world spent millions of dollars in court attempting to reverse the biggest defeat the pharmaceutical industry suffered in decades. The Supreme Court recently declined even to hear their cases. For these companies, the legal fight is now over. But the pharmaceutical industry’s […]